| Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
Nodes: 87,
Authors: 292,
Journals: 42,
Outer References: 2132,
Words: 349
Collection span: 2003 - 2004
View: Overview. Sorted by LCR.
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
|---|---|---|---|---|---|
| 1 | 26 | 106 | 73 2004 NATURE REVIEWS IMMUNOLOGY 4(11):868-877 Harris RS; Liddament MT Retroviral restriction by APOBEC proteins | 0 | 0 |
| 2 | 20 | 101 | 72 2004 NATURE IMMUNOLOGY 5(11):1109-1115 Bieniasz PD Intrinsic immunity: a front-line defense against viral attack | 0 | 0 |
| 3 | 16 | 34 | 25 2004 CURRENT BIOLOGY 14(15):1385-1391 Liddament MT; Brown WL; Schumacher AJ; Harris RS APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo | 3 | 4 |
| 4 | 16 | 33 | 44 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(33):34083-34086 Alce TM; Popik W APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein | 2 | 2 |
| 5 | 15 | 49 | 67 2004 JOURNAL OF VIROLOGY 78(21):12041-12046 Gaddis NC; Sheehy AM; Ahmad KM; Swanson CM; Bishop KN; et al. Further investigation of simian immunodeficiency virus vif function in human cells | 0 | 0 |
| 6 | 13 | 59 | 75 2004 NUCLEIC ACIDS RESEARCH 32(8):2421-2429 Suspene R; Sommer P; Henry M; Ferris S; Guetard D; et al. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase | 0 | 0 |
| 7 | 13 | 70 | 85 2004 TRENDS IN MOLECULAR MEDICINE 10(6):291-297 Rose KM; Marin M; Kozak SL; Kabat D The viral infectivity factor (Vif) of HIV-1 unveiled | 1 | 1 |
| 8 | 12 | 30 | 26 2004 CURRENT BIOLOGY 14(15):1392-1396 Bishop KN; Holmes RK; Sheehy AM; Davidson NO; Cho SJ; et al. Cytidine deamination of retroviral DNA by diverse APOBEC proteins | 4 | 5 |
| 9 | 12 | 96 | 66 2004 JOURNAL OF VIROLOGY 78(21):11841-11852 Luo K; Liu BD; Xiao ZX; Yu YK; Yu XH; et al. Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging | 0 | 0 |
| 10 | 11 | 32 | 35 2004 EMBO JOURNAL 23(12):2451-2458 Wiegand HL; Doehle BP; Bogerd HP; Cullen BR A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins | 6 | 7 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 11 | 11 | 23 | 36 2004 EMBO REPORTS 5(7):679-680 Trono D Retroviruses under editing crossfire - A second member of the human APOBEC3 family is a Vif-blockable innate antiretroviral factor | 0 | 0 |
| 12 | 11 | 50 | 38 2004 HUMAN MOLECULAR GENETICS 13(16):1785-1791 Zhang JZ; Webb DM Rapid evolution of primate antiviral enzyme APOBEC3G | 1 | 2 |
| 13 | 11 | 50 | 76 2004 PLOS BIOLOGY 2(9):1278-1285 Sawyer SL; Emerman M; Malik HS Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G | 0 | 0 |
| 14 | 10 | 33 | 45 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(34):35822-35828 Svarovskaia ES; Xu HZ; Mbisa JL; Barr R; Gorelick RJ; et al. Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 Virions through interactions with viral and nonviral RNAs | 3 | 3 |
| 15 | 10 | 33 | 59 2004 JOURNAL OF VIROLOGY 78(15):8238-8244 Kobayashi M; Takaori-Kondo A; Shindo K; Abudu A; Fukunaga K; et al. APOBEC3G targets specific virus species | 1 | 1 |
| 16 | 10 | 20 | 87 2004 VIROLOGY 328(2):163-168 Schafer A; Bogerd HP; Cullen BR Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor | 0 | 0 |
| 17 | 9 | 53 | 43 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(32):33177-33184 Cen S; Guo F; Niu MJ; Saadatmand J; Deflassieux J; et al. The interaction between HIV-1 Gag and APOBEC3G | 4 | 4 |
| 18 | 9 | 37 | 57 2004 JOURNAL OF VIROLOGY 78(11):6073-6076 Zheng YH; Irwin D; Kurosu T; Tokunaga K; Sata T; et al. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication | 8 | 10 |
| 19 | 9 | 24 | 68 2004 JOURNAL OF VIROLOGY 78(21):12058-12061 Zennou W; Perez-Caballero D; Gottlinger H; Bieniasz PD APOBEC3G incorporation into human immunodeficiency virus type 1 particles | 0 | 0 |
| 20 | 8 | 46 | 41 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(13):12355-12362 Akari H; Fujita M; Kao S; Khan MA; Shehu-Xhilaga M; et al. High level expression of human immunodeficiency virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the gag precursor at the p2/nucleocapsid processing site | 2 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 21 | 8 | 34 | 71 2004 MICROBES AND INFECTION 6(9):791-798 Fujita M; Akari H; Sakurai A; Yoshida A; Chiba T; et al. Expression of HIV-1 accessory protein Vif is controlled uniquely to be low and optimal by proteasome degradation | 0 | 0 |
| 22 | 8 | 28 | 78 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(11):3770-3774 Bogerd HP; Doehle BP; Wiegand HL; Cullen BR A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor | 15 | 16 |
| 23 | 8 | 32 | 80 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(15):5652-5657 Xu HZ; Svarovskaia ES; Barr R; Zhang YJ; Khan MA; et al. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion | 8 | 8 |
| 24 | 7 | 45 | 28 2004 CURRENT OPINION IN IMMUNOLOGY 16(4):477-482 Navarro F; Landau NR Recent insights into HIV-1 Vif | 1 | 2 |
| 25 | 6 | 21 | 23 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 321(3):566-573 Douaisi M; Dussart S; Courcoul M; Bessou G; Vigne R; et al. HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles | 0 | 0 |
| 26 | 6 | 38 | 30 2004 CURRENT OPINION IN MICROBIOLOGY 7(5):555-559 Trkola A HIV-host interactions: vital to the virus and key to its inhibition (vol 7, pg 555, 2004) | 1 | 1 |
| 27 | 6 | 39 | 40 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(9):7792-7798 Mehle A; Strack B; Ancuta P; Zhang CS; McPike M; et al. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway | 13 | 13 |
| 28 | 6 | 17 | 42 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(15):14481-14483 Mangeat B; Turelli P; Liao SY; Trono D A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to vif action | 10 | 10 |
| 29 | 6 | 24 | 46 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(42):43371-43373 Turelli P; Vianin S; Trono D The innate antiretroviral factor APOBEC3G does not affect human LINE-1 retrotransposition in a cell culture assay | 0 | 0 |
| 30 | 6 | 80 | 49 2004 JOURNAL OF IMMUNOLOGY 172(11):6513-6518 Cascalho M Advantages and disadvantages of cytidine deamination | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 31 | 6 | 24 | 77 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(11):3725-3726 Kaiser SM; Emerman M Controlling lentiviruses: Single amino acid changes can determine specificity | 0 | 0 |
| 32 | 6 | 30 | 79 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(11):3927-3932 Schrofelbauer R; Chen D; Landau NR A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif) | 0 | 0 |
| 33 | 5 | 37 | 29 2004 CURRENT OPINION IN MICROBIOLOGY 7(4):407-411 Trkola A HIV-host interactions: vital to the virus and key to its inhibition | 0 | 0 |
| 34 | 5 | 66 | 54 2004 JOURNAL OF VIROLOGY 78(4):2072-2081 Liu BD; Yu XH; Luo K; Yu YK; Yu XF Influence of primate lentiviral vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G | 8 | 9 |
| 35 | 5 | 10 | 70 2004 M S-MEDECINE SCIENCES 20(2):139-141 Schwartz O HIV-1, a very Vif virus | 0 | 0 |
| 36 | 5 | 36 | 74 2004 NATURE STRUCTURAL & MOLECULAR BIOLOGY 11(5):435-442 Yu Q; Konig R; Pillai S; Chiles K; Kearney M; et al. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome | 9 | 11 |
| 37 | 4 | 29 | 32 2004 DNA REPAIR 3(1):85-89 Bhagwat AS DNA-cytosine deaminases: from antibody maturation to antiviral defense | 1 | 1 |
| 38 | 4 | 29 | 47 2004 JOURNAL OF CELLULAR BIOCHEMISTRY 92(3):560-572 Li JL; Potash MJ; Volsky DJ Functional domains of APOBEC3G required for antiviral activity | 1 | 1 |
| 39 | 4 | 171 | 53 2004 JOURNAL OF MOLECULAR MEDICINE-JMM 82(5):280-297 Krokan HE; Kavli B; Slupphaug G Novel aspects of macromolecular repair and relationship to human disease | 0 | 2 |
| 40 | 4 | 45 | 62 2004 JOURNAL OF VIROLOGY 78(19):10574-10581 Feng F; Davis A; Lake JA; Carr J; Xia W; et al. Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 41 | 4 | 33 | 64 2004 JOURNAL OF VIROLOGY 78(20):11070-11076 An P; Bleiber G; Duggal P; Nelson G; May M; et al. APOBEC3G genetic variants and their influence on the progression to AIDS | 0 | 0 |
| 42 | 4 | 45 | 65 2004 JOURNAL OF VIROLOGY 78(21):11816-11822 Ikeda Y; Ylinen LMJ; Kahar-Bador M; Towers GJ Influence of gag on human immunodeficiency virus type 1 species-specific tropism | 0 | 0 |
| 43 | 4 | 42 | 82 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(29):10780-10785 Keckesova Z; Ylinen LMJ; Towers GJ The human and African green monkey TRIM5 alpha genes encode Ref1 and Lv1 retroviral restriction factor activities | 2 | 5 |
| 44 | 4 | 24 | 83 2004 TRENDS IN MICROBIOLOGY 12(4):145-148 Argyris EG; Pomerantz RJ HIV-1 Vif versus APOBEC3G: newly appreciated warriors in the ancient battle between virus and host | 0 | 0 |
| 45 | 3 | 21 | 3 2003 CURRENT BIOLOGY 13(22):2009-2013 Conticello SG; Harris RS; Neuberger MS The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G | 23 | 26 |
| 46 | 3 | 16 | 20 2004 AIDS 18(13):1861-1863 Berkhout B; de Ronde A APOBEC3G versus reverse transcriptase in the generation of HIV-1 drug-resistance mutations | 0 | 0 |
| 47 | 3 | 14 | 21 2004 AIDS 18(13):1863-1865 Min W; Hui X; Hong KX; Huang HL; Tang HL; et al. Biased G-to-A hypermutation in HIV-1 proviral DNA from a long-term non-progressor | 0 | 0 |
| 48 | 3 | 96 | 48 2004 JOURNAL OF IMMUNOLOGY 172(10):5815-5821 Wang CL; Wabl M DNA acrobats of the Ig class switch | 0 | 2 |
| 49 | 2 | 20 | 18 2003 TRENDS IN MOLECULAR MEDICINE 9(10):409-413 Vartanian JP; Sommer P; Wain-Hobson S Death and the retrovirus | 8 | 9 |
| 50 | 2 | 66 | 22 2004 AIDS RESEARCH AND HUMAN RETROVIRUSES 20(3):285-295 Swiggard WJ; O'Doherty U; McGain D; Jeyakumar D; Malim MH Long HIV type 1 reverse transcripts can accumulate stably within resting CD4(+) T cells while short ones are degraded | 1 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 51 | 2 | 33 | 34 2004 DNA REPAIR 3(7):687-692 Steele EJ DNA polymerase-eta as a reverse transcriplase: implications for mechanisms of hypermutation in innate anti-retroviral defences and antibody SHM systems | 0 | 0 |
| 52 | 2 | 53 | 60 2004 JOURNAL OF VIROLOGY 78(16):8799-8811 Garcin D; Marq JB; Iseni F; Martin S; Kolakofsky D A short peptide at the amino terminus of the Sendai virus C protein acts as an independent element that induces STAT1 instability | 0 | 0 |
| 53 | 2 | 42 | 63 2004 JOURNAL OF VIROLOGY 78(19):10747-10754 Ciuffi A; Bleiber G; Munoz M; Martinez R; Loeuillet C; et al. Entry and transcription as key determinants of differences in CD4 T-cell permissiveness to human immunodeficiency virus type 1 infection | 0 | 0 |
| 54 | 2 | 70 | 84 2004 TRENDS IN MICROBIOLOGY 12(4):170-177 Freed EO HIV-1 and the host cell: an intimate association | 0 | 0 |
| 55 | 1 | 20 | 2 2003 CELL 114(3):281-283 Goff SP Death by deamination: A novel host restriction system for HIV-1 | 6 | 9 |
| 56 | 1 | 26 | 4 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(45):44412-44416 Shindo K; Takaori-Kondo A; Kobayashi M; Abudu A; Fukunaga K; et al. The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity | 7 | 9 |
| 57 | 1 | 47 | 5 2003 JOURNAL OF VIROLOGY 77(21):11398-11407 Kao S; Khan MA; Miyagi E; Plishka R; Buckler-White A; et al. The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity | 19 | 24 |
| 58 | 1 | 45 | 6 2003 MOLECULAR CELL 12(2):501-508 Barreto V; Reina-San-Martin B; Ramiro AR; McBride KM; Nussenzweig MC C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation and gene conversion | 2 | 20 |
| 59 | 1 | 30 | 7 2003 MOLECULAR CELL 12(3):591-601 Stopak K; de Noronha C; Yonemoto W; Greene WC HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability | 39 | 50 |
| 60 | 1 | 15 | 8 2003 MOLECULAR THERAPY 8(4):525-527 Cullen BR HIV-1 Vif: Counteracting innate antiretroviral defenses | 1 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 61 | 1 | 18 | 9 2003 NATURE 424(6944):21-22 Gu YP; Sundquist WI Good to CU | 6 | 6 |
| 62 | 1 | 29 | 10 2003 NATURE IMMUNOLOGY 4(7):641-643 Harris RS; Sheehy AM; Craig HM; Malim MH; Neuberger MS DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses | 7 | 9 |
| 63 | 1 | 40 | 11 2003 NATURE MEDICINE 9(11):1398-1403 Marin M; Rose KM; Kozak SL; Kabat D HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation | 41 | 55 |
| 64 | 1 | 25 | 12 2003 NATURE MEDICINE 9(11):1404-1407 Sheehy AM; Gaddis NC; Malim MH The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif | 40 | 52 |
| 65 | 1 | 4 | 13 2003 NATURE REVIEWS IMMUNOLOGY 3(7):517-517 O'Connell D HIV - One step forward ... one step back | 0 | 0 |
| 66 | 1 | 118 | 14 2003 NATURE REVIEWS MICROBIOLOGY 1(3):181-190 Simon V; Ho DD HIV-1 dynamics in vivo: Implications for therapy | 0 | 0 |
| 67 | 1 | 29 | 15 2003 SCIENCE 301(5635):923-925 KewalRamani VN; Coffin JM Weapons of mutational destruction | 1 | 7 |
| 68 | 1 | 27 | 16 2003 SCIENCE 302(5647):1056-1060 Yu XH; Yu YK; Liu BD; Luo K; Kong W; et al. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex | 37 | 47 |
| 69 | 1 | 40 | 17 2003 SEMINARS IN IMMUNOLOGY 15(4):201-208 Hayday AC; Pennington DJ; Giuggio VM Genomics and immunology | 0 | 0 |
| 70 | 1 | 106 | 19 2003 VIRAL IMMUNOLOGY 16(4):461-474 Navas-Martin S; Weiss SR SARS: Lessons learned from other coronaviruses | 0 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 71 | 1 | 1 | 24 2004 CELL 116(4) Harris RS; Bishop KN; Sheehy AM; Craig HM; Petersen-Mahrt SK; et al. DNA deamination mediates innate immunity to retroviral infection (vol 113, pg 803, 2003) | 0 | 0 |
| 72 | 1 | 36 | 27 2004 CURRENT OPINION IN GENETICS & DEVELOPMENT 14(1):5-10 Friedberg EC; McDaniel LD; Schultz RA The role of endogenous and exogenous DNA damage and mutagenesis | 0 | 3 |
| 73 | 1 | 237 | 31 2004 CURRENT PHARMACEUTICAL DESIGN 10(30):3725-3739 Muriaux D; Darlix JL; Cimarelli A Targeting the assembly of the human immunodeficiency virus type I | 0 | 1 |
| 74 | 1 | 33 | 33 2004 DNA REPAIR 3(5):505-513 Fischer JA; Muller-Weeks S; Caradonna S Proteolytic degradation of the nuclear isoform of uracil-DNA glycosylase occurs during the S phase of the cell cycle | 0 | 0 |
| 75 | 1 | 26 | 37 2004 EUROPEAN JOURNAL OF IMMUNOLOGY 34(3):844-849 Fugmann SD; Rush JS; Schatz DG Non-redundancy of cytidine deaminases in class switch recombination | 0 | 2 |
| 76 | 1 | 124 | 39 2004 INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY 36(9):1716-1734 Rezende LF; Prasad VR Nucleo side-analog resistance mutations in HIV-1 reverse transcriptase and their influence on polymerase fidelity and viral mutation rates | 0 | 0 |
| 77 | 1 | 39 | 50 2004 JOURNAL OF INFECTIOUS DISEASES 189(4):567-571 Pomerantz RJ HIV-1 infection and genomics: Sorting out the complexity | 0 | 0 |
| 78 | 1 | 79 | 51 2004 JOURNAL OF MEDICAL VIROLOGY 73(3):350-361 Pariente N; Pernas M; de la Rosa R; Gomez-Mariano G; Fernandez G; et al. Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes | 0 | 1 |
| 79 | 1 | 57 | 52 2004 JOURNAL OF MOLECULAR BIOLOGY 337(3):585-596 Beale RCL; Petersen-Mahrt SK; Watt IN; Harris RS; Rada C; et al. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: Correlation with mutation spectra in vivo | 8 | 12 |
| 80 | 1 | 47 | 55 2004 JOURNAL OF VIROLOGY 78(5):2426-2433 Gao F; Chen Y; Levy DN; Conway JA; Kepler TB; et al. Unselected mutations in the human immunodeficiency virus type 1 genome are mostly nonsynonymous and often deleterious | 2 | 3 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 81 | 1 | 57 | 56 2004 JOURNAL OF VIROLOGY 78(8):4234-4247 Charpentier C; Dwyer DE; Mammano F; Lecossier D; Clavel F; et al. Role of minority populations of human immunodeficiency virus type 1 in the evolution of viral resistance to protease inhibitors | 0 | 0 |
| 82 | 1 | 54 | 58 2004 JOURNAL OF VIROLOGY 78(14):7565-7574 Pastore C; Ramos A; Mosier DE Intrinsic obstacles to human immunodeficiency virus type 1 coreceptor switching | 0 | 0 |
| 83 | 1 | 79 | 61 2004 JOURNAL OF VIROLOGY 78(17):9524-9537 Llano M; Vanegas M; Fregoso O; Saenz D; Chung S; et al. LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes | 0 | 0 |
| 84 | 1 | 81 | 69 2004 JOURNAL OF VIROLOGY 78(22):12537-12547 Baumann JG; Unutmaz D; Miller MD; Breun SKJ; Grill SM; et al. Murine T cells potently restrict human immunodeficiency virus infection | 0 | 0 |
| 85 | 1 | 37 | 81 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(29):10774-10779 Hatziioannou T; Perez-Caballero D; Yang A; Cowan S; Bieniasz PD Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5 alpha | 1 | 4 |
| 86 | 1 | 57 | 86 2004 VIROLOGY 318(1):350-359 Kristbjornsdottir HB; Andresdottir V; Svansson V; Torsteinsdottir S; Matthiasdottir S; et al. The vif gene of maedi-visna virus is essential for infectivity in vivo and in vitro | 0 | 0 |
| 87 | 0 | 23 | 1 2003 CELL 113(6):803-809 Harris RS; Bishop KN; Sheehy AM; Craig HM; Petersen-Mahrt SK; et al. DNA determination mediates innate immunity to retroviral infection | 86 | 86 |
Generated by: HistCite 2004.11.12